Company profile: Vita 34
1.1 - Company Overview
Company description
- Provider of stem cell services in Europe, including collection, processing, storage, preservation, and retrieval of stem cells from umbilical cord blood and tissue. Offerings include VitaMine&Yours for umbilical cord tissue preparation for cryo-preservation and VitaPlusDonation for personal stem cell deposits for healthcare use.
Products and services
- Stem Cell Preservation: Cryogenic preservation of umbilical cord-derived stem cells to maintain long-term viability for future therapeutic applications, ensuring readiness for medical treatments when needed
- Stem Cell Processing: Laboratory-grade preparation of collected umbilical cord stem cells and tissue using VitaMine&Yours, readying tissue for cryo-preservation and future medical use
- Stem Cell Storage: Cryogenic, personal deposit storage of umbilical cord blood and tissue-derived stem cells collected at birth, via VitaPlusDonation, held for personal health care use
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vita 34
IBL International
HQ: Germany
Website
- Description: Provider of immunoassays and antibodies/in-vitro diagnostic assays for research, clinical, and specialty laboratories; develops, manufactures, and distributes assays focused on special and rare indications in endocrinology, neonatal screening, and the diagnosis of stress parameters and steroid hormones.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IBL International company profile →
Scireq
HQ: Canada
Website
- Description: Provider of laboratory equipment for preclinical respiratory research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scireq company profile →
Breath Therapeutics
HQ: Germany
Website
- Description: Provider of inhaled investigational therapies for rare respiratory diseases, combining novel formulations of existing drugs with cutting-edge inhalation technology. Pipeline includes Liposomal Cyclosporine A for Inhalation for bronchiolitis obliterans syndrome to deliver drug to lungs while minimizing systemic exposure, and inhaled colistimethate sodium for non-cystic fibrosis bronchiectasis targeting Pseudomonas aeruginosa.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Breath Therapeutics company profile →
Arzeda
HQ: United States
Website
- Description: Provider of AI-driven protein and enzyme design and manufacturing for pharmaceuticals, industrial chemicals, and food applications. Offers Intelligent Protein Design Technology to create novel proteins; ProSweet enzymes for efficient production of Reb D and Reb M from stevia; and collaborates with Unilever (cleaning), W. L. Gore (materials), Takeda (therapeutic biologics), and AAK (plant-based oils).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arzeda company profile →
Caliper Life Sciences
HQ: United States
Website
- Description: Provider of integrated systems consisting of instruments, software and reagents, laboratory automation tools, and assay and discovery services for pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caliper Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vita 34
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vita 34
2.2 - Growth funds investing in similar companies to Vita 34
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vita 34
4.2 - Public trading comparable groups for Vita 34
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →